Integrative Aesthetics: Shaping the Emerging Frontier of Modern Aesthetic Medicine

Abstract

Aesthetic medicine is moving beyond an appearance-centered focus toward approaches that also prioritize long-term skin and underlying tissue health. Skin health and systemic health are now widely recognized as closely interconnected through shared mechanisms of aging biology, yet a practical clinical construct for translating this understanding into aesthetic practice remains to be established. In this conceptual review article, we propose Integrative Aesthetics (IA) as a clinically grounded framework that positions aesthetic and systemic health improvement as coequal, mutually reinforcing clinical goals, organized through 2 interconnected layers: local tissue optimization and systemic health optimization. These aims are operationalized through 3 synergistic pillars: i) conventional aesthetic interventions, ii) regenerative therapies, and iii) functional medicine. Conventional aesthetic interventions provide direct structural and surface-level correction; regenerative therapies support tissue quality by modulating the local microenvironment and repair pathways; and functional medicine addresses modifiable upstream determinants of tissue responsiveness, including nutrition, mitochondrial function, endocrine status, lifestyle, and broader biological aging processes. By integrating local and systemic strategies, IA proposes a mutually reinforcing model in which improved systemic health enhances procedural readiness, recovery, and remodeling, while improved skin and supporting tissue health, and the visible aesthetic benefits they produce, may support broader patient engagement in long-term health optimization. IA therefore offers a practical framework for reorienting aesthetic medicine toward a more whole-person, multidisciplinary, and health-focused model of care.

Introduction

Aesthetic medicine has traditionally focused on enhancing physical appearance. However, the field is being reshaped by the emergence of “regenerative aesthetics”, an approach that links visible signs of aging to the health of skin and underlying supporting tissues and seeks to improve tissue integrity and remodeling capacity in ways that support more youthful, native-like structure and function.^1–4 This shift mirrors a wider trend across medicine toward extension of healthspan, emphasizing sustained functional preservation rather than episodic disease treatment.⁵ In aesthetic practice, this is reflected in emerging concepts such as “skinspan”, defined as the period during which skin remains youthful-appearing and healthy.⁶

Alongside this evolution is growing recognition that patient health is a direct and often limiting determinant of aesthetic outcomes.^7–9 Contemporary perspectives define health not only as the complete state of physical, mental, and social well-being¹⁰ but as a dynamic capacity to adapt and self-manage in response to physical, mental, and social challenges.¹¹ Biologically, this capacity reflects cellular and tissue resilience, including the ability to sense and repair damage, maintain structural and functional integrity, and adapt to cumulative stress with advancing age.¹² These same processes shape how skin and supporting tissue structures respond to aesthetic procedures and determine the durability of treatment benefits; therefore, patient-level determinants can contribute to substantial variability in outcomes and should be considered in treatment planning.

While calls for more holistic practice appear in the aesthetic medicine literature,^1,2,13 a practical clinical construct to guide implementation is still emerging. Here, we propose Integrative Aesthetics (IA) as a framework that aligns local, tissue-targeted treatment with global, systemic optimization to address both aesthetic outcomes and whole-body health. This conceptual review is informed by the authors’ clinical and scientific expertise and supported by a non-systematic, content-led review of literature relating to skin and systemic health, aging biology, aesthetic and regenerative interventions, and systemic determinants of tissue health. Sources were selected based on their relevance to the concepts underpinning the proposed framework.

Skin and Systemic Health are Interconnected

When health is framed as a functional capacity for resilience and repair, aging can be understood as the progressive decline of that capacity, driven by interconnected molecular, cellular, and systemic changes that reduce the body’s ability to maintain homeostasis and increase vulnerability to internal/external stressors.¹⁴ Skin and underlying tissue health are shaped by the same systemic health factors and aging biology, and therefore should not be considered in isolation.

Systemic factors that influence health involve multiple interconnected domains and extend beyond lifestyle measures alone. This can be conceptualized using a house analogy in which the body is our home and its long-term health depends on the strength of its foundations, how its core systems are regulated, the quality of its maintenance and protection, and how it is lived in and cared for. Foundational determinants, including genetic/epigenetic factors, establish baseline capacity for tissue maintenance and repair.^15,16 Built on this foundation are regulatory systems, including metabolic, endocrine, and circadian control, that shape the systemic environment needed to sustain homeostasis and coordinate repair and remodeling.^17–20 Protective mechanisms, including immune function and key modulators such as nutrition and the microbiome, help preserve physiologic stability by limiting cumulative damage and supporting recovery.^21–23 Exposures across the life course, including nonmodifiable early-life conditions (eg, childhood psychosocial stress) and modifiable environmental and lifestyle factors, can modulate these systems by shaping epigenetic, neuroendocrine, inflammatory, and metabolic regulation.^2,24 Psychosocial context, including social connectedness, sense of purpose, and the perceived chronicity/controllability of stress, further influences systemic resilience through neuroendocrine and inflammatory pathways.^25–27 Together, these factors define the aging trajectories and, consequently, skin and underlying tissue health. Therefore, when the goal is to reduce the visible signs of skin aging and sustain procedural benefit, these systemic factors should be considered and optimized where feasible.

At the same time, skin health should not be viewed only as a passive readout of systemic aging. Growing evidence suggests that skin health may also play a more active role in biological aging and disease development than previously appreciated, given that the skin serves as a major interface with the exposome (ie, the cumulative burden of environmental exposures over time).²⁸ Studies have associated chronic inflammatory skin diseases (eg, atopic dermatitis and psoriasis) and/or barrier dysfunction with systemic comorbidities, including a higher risk of cardiovascular diseases²⁹ and greater prevalence of type 2 diabetes³⁰ with additional links to cognitive impairment³¹ and bone loss.³² Consistent with this, impairment of the skin barrier, either through acute injury or aging-related changes, has been shown to increase the production of pro-inflammatory cytokines.^33–35 Consequently, age-related decline in skin barrier may be an upstream contributor to low-level systemic inflammation (ie, inflammaging),^7,31 a hallmark of aging and a cross-cutting driver that contributes to other hallmark pathways.^36,37 Emerging evidence further suggests that improving skin condition can benefit certain health issues (eg, mild cognitive impairment and insulin sensitivity) in older adults.^38–40 Hence, the current view is that good skin health is not merely cosmetic; by supporting barrier integrity/function, it can help lower the body’s cumulative inflammatory load and may contribute to improved systemic resilience over time.

Given this bidirectional relationship, aesthetic medicine should move toward a whole-person paradigm in which skin health and systemic health are addressed together.

Integrative Aesthetics

This whole-person paradigm can be illustrated using a tree analogy that represents the human body as an interconnected living system (Figure 1). Aesthetic concerns (eg, wrinkles, laxity, pigmentation) are one of many visible manifestations (leaves) that stem from deeper systemic (roots), tissue- and cellular-level (trunk/branches) drivers. Simultaneously, the health of the leaves also influences the vitality of the whole tree, a reciprocal relationship analogous to the interaction between systemic health and the health of the skin and underlying supporting tissues. This shift, from focusing on “leaves” alone to managing the whole “tree”, positions skin and underlying tissue health as an integrated component of healthy aging rather than a purely cosmetic endpoint.

Figure 1.

Foundations of Integrative Aesthetics. The tree represents the foundations of Integrative Aesthetics, illustrating the human body as an interconnected whole. The roots reflect the systemic and foundational drivers of health; the trunk and branches denote localized tissue health, structure, and function; and the leaves represent the visible signs of health expressed through the skin and other external features. All layers are interdependent and support one another, reflecting the continuous interaction between systemic health and external expression.

Translating this “whole tree” view into clinical practice requires a model that intentionally combines local tissue remodeling with strategies that strengthen systemic determinants of repair and resilience. The phrase “integrative aesthetics” is sometimes used informally to describe this direction of care; however, to our knowledge, it has not been defined as a clinically grounded, evidence-based framework in peer-reviewed literature. Here, we define IA as an interdisciplinary model that positions aesthetic optimization and systemic health improvement as coequal, mutually reinforcing clinical goals.

Within this IA framework, there are three pillars that operationalize IA in clinical practice, each addressing interdependent dimensions of aesthetic and systemic care: i) conventional aesthetic interventions, ii) regenerative therapies, and iii) functional medicine (Table 1). Conventional and regenerative aesthetic interventions comprise the local correction layer, with conventional interventions directly providing structural correction, whereas regenerative approaches additionally aim to restore tissue quality by leveraging patient’s intrinsic repair and remodeling mechanisms. Functional medicine constitutes the global correction layer, targeting modifiable systemic factors that shape tissue responsiveness, recovery, and long-term remodeling. This local-global structure reflects a central principle of IA and is key to optimal outcomes.

Table 1.

Pillars of Integrative Aesthetics and Representative Interventions

Pillar	Primary Focus Within IA	Representative Interventions*, **
Conventional aesthetic interventions	Correction of visible signs of aging through tissue-targeted modulation of architecture, biomechanics, and/or surface irregularities Functions within the local correction layer	Non/minimally invasive procedures BoNT-A HA fillers Energy-based devices (eg, laser, RF, MFU-V) Topical cosmeceuticals Retinoids Vitamin C Niacinamide Other topical active ingredients (eg, peptides, hydroxy acids, ceramides, and barrier lipids) Photoprotection
Regenerative therapies	Enhancement of intrinsic repair pathways and progressive remodeling through modulation of local microenvironment Functions within the local correction layer	Biostimulatory scaffolds (eg, CaHA-CMC, PLLA) Bio-cue based approaches (eg, PRP, EVs) Emerging modalities (eg, polynucleotides, photobiomodulation)
Functional medicine	Identification and management of modifiable systemic factors (root causes) that influence repair capacity, resilience, and longer-term remodeling Functions within the global correction layer	Nutrition-focused strategies and targeted supplementation Improvement of skin and gut microbiome (eg, dietary modulation, pre-/probiotics) Endocrine optimization (eg, HRT, correction of clinically relevant endocrine dysfunction) Lifestyle regulation (eg, sleep, physical activity, psychosocial stress) Emerging longevity-oriented interventions targeting hallmarks of aging (eg, rapamycin, NAD+ precursor)

Notes: *Examples are illustrative and non-exhaustive. Selection, sequencing, and/or dosing should be individualized based on patient presentation, risk profile, clinical indication, local regulations, and/or clinician scope of practice. **The evidence base and clinical positioning of certain regenerative modalities and longevity-oriented interventions continue to evolve. Off-label use may be variably regulated across regions.

Abbreviations: BoNT-A, botulinum toxin type A; CaHA-CMC, calcium hydroxyapatite–carboxymethyl cellulose; ECM, extracellular matrix; EVs, extracellular vesicles; HA, hyaluronic acid; HRT, hormone replacement therapy; IA, integrative aesthetics; MFU-V, microfocused ultrasound with visualization; NAD, nicotinamide adenine dinucleotide; PLLA, poly-L-lactic acid; PRP, platelet-rich plasma; RF, radiofrequency.

Local Tissue Optimization

Tissue behavior and proper cellular function are strongly influenced by the local environment, including the composition and organization of the extracellular matrix (ECM), its biomechanical and biochemical properties, and interactions between immune and stromal cells.^41–44 The ECM forms a dynamic scaffold composed of functionally distinct components, including collagens, elastins, glycoproteins, proteoglycans, and glycosaminoglycans. It supports cells within the skin, including fibroblasts, keratinocytes, endothelial cells, and immune cells, while also regulating cellular behavior through cell–matrix interactions and by serving as a reservoir for growth factors and cytokines.^41–43 Although understanding this complex biology is important, a detailed review of ECM composition and the molecular and structural biology of skin aging is beyond the scope of this conceptual review. The brief overview below is intended to explain why the local tissue microenvironment is an important target for intervention in IA; comprehensive discussions of these topics are available elsewhere.^42,43

Among the cells supported by this matrix, fibroblasts act as key effectors of repair and ECM renewal and respond to ECM-derived biochemical and biophysical cues that regulate adhesion, migration, and matrix synthesis.^45–47 In young dermis, fibroblast adhesion to an intact collagen-rich ECM helps maintain a stretched, elongated morphology.⁴⁸ This mechanical state supports transforming growth factor beta (TGF-β)/Smad signaling and the synthesis of type I collagen, which provides tensile strength; type III collagen, which contributes to tissue compliance and repair; and other matrix components, including elastin, which enables skin recoil after deformation.^42,48,49 Aging and chronic photodamage disrupt this relationship by inducing collagen loss and fragmentation, reducing fibroblast–ECM contact and mechanical stimulation. Chronic photodamage also disrupts elastic-fiber organization and may lead to solar elastosis, further compromising normal skin recoil.⁴³ Fibroblasts consequently become smaller and less spread, with impaired TGF-β signaling, reduced matrix production, and increased matrix metalloproteinase (MMP) activity.^42,43 The accumulation of senescent fibroblasts further alters the local environment through pro-inflammatory and matrix-degrading mediators that can impair neighboring cells.⁵⁰ Together, these changes progressively disrupt the biomechanical and biochemical conditions required for ECM homeostasis. The condition of this microenvironment can influence how the tissue responds to interventions intended to stimulate repair and remodeling, including whether the response progresses toward organized repair and homeostasis or persists as maladaptive tissue remodeling.^51,52 Therefore, local interventions (ie, conventional and regenerative aesthetic therapies) are a necessary component of IA as they directly shape the microenvironment in which regeneration and remodeling occur.

Conventional Aesthetic Interventions

Conventional aesthetic interventions, including non/minimally invasive treatments and topical cosmeceuticals, focus on restoring or enhancing appearance by directly addressing tissue architecture and biomechanics (eg, muscle activity and structural support), surface irregularities, as well as hallmark manifestations of aging such as volume loss, skin laxity, and textural changes (Table 1).⁵³

Representative non/minimally invasive treatment modalities include botulinum toxin type A (BoNT-A), hyaluronic acid (HA) fillers, and energy-based therapies (eg, laser, radiofrequency [RF], and microfocused ultrasound with visualization). BoNT-A is primarily used to relax mimetic muscles and soften dynamic facial lines.^54,55 When applied as intradermal microdroplets (ie, microtoxin technique), its therapeutic scope broadens to supporting improvements in pore size, sebum regulation, inflammatory skin conditions, fine lines, and contour refinement in areas such as the jawline and neck.⁵⁵ HA fillers, in addition to their established role in restoring volume and contour, can enhance dermal hydration, support ECM stability, and promote fibroblast function, with associated improvements in radiance, texture, and related skin quality parameters.^56,57 Energy-based therapies, on the other hand, deliver energy that is converted to heat within tissue at targeted depths, ranging from superficial dermis to deeper fascial planes, including superficial musculoaponeurotic system, depending on technology and device parameters.^58,59 This controlled thermal effect induces collagen denaturation and wound-healing cascades associated with neocollagenesis/elastin remodeling, translating clinically to improvements in laxity, firmness, and texture.^58,60

Topical cosmeceuticals are a foundational component of IA, serving as daily interventions that reinforce the skin barrier, provide photoprotection, and address ongoing biological drivers of visible aging, including oxidative stress and inflammation.^6,61 For instance, topical retinoids promote epidermal renewal and collagen synthesis, in part through downregulation of MMPs and increased type I collagen production.^54,62 Clinically, they have consistently been shown to improve photoaging features such as wrinkles, hyperpigmentation, and skin texture.^54,62 Topical vitamin C helps stabilize collagen fibers and reduce collagen degradation and, when used regularly in optimized formulations, has been shown to improve skin texture, reduce uneven pigmentation, and protect against photodamage.^62,63 Niacinamide has also been shown to improve aging skin appearance and barrier-related outcomes, and is frequently positioned as a barrier-supportive and anti-inflammatory active ingredient.^62,64 Other topical active ingredients (eg, peptides, hyaluronic acid, hydroxy acids, ceramides, and barrier lipids), along with broad-spectrum sunscreen, can also be layered in to address specific skin concerns and support photoprotection; a broader overview of commonly used cosmeceutical ingredients is discussed in detail elsewhere.⁵⁴ Within IA, these daily therapies also support procedural readiness and recovery when incorporated into the overall regimen before and after aesthetic procedures, helping to mitigate common post-procedural reactions and sustain longer-term outcomes.⁶⁵

In IA, conventional interventions primarily offer immediate visible corrections, such as shape, support, motion modulation, and tightening. At the same time, they can trigger a wound-healing response that activates fibroblasts, promoting long-term neocollagenesis and structural remodeling.

Regenerative Therapies

Regenerative aesthetic interventions aim to restore tissue toward healthier structure and function. Achieving this requires more than cellular activation or increased collagen production, as the newly formed ECM must also be appropriately organized and integrated so that the tissue regains native-like mechanical and physiological properties (Table 1).^1,2

Major approaches in regenerative aesthetics include cellular therapies, biochemical cues, and biostimulatory scaffolds.^1,66 As an emerging field, the evidence base and clinical positioning of individual modalities continue to evolve; however, several modalities, such as calcium hydroxyapatite-carboxymethyl cellulose (CaHA-CMC), poly-L-lactic acid (PLLA), polynucleotides, poly-micronutrients, growth factors, platelet-rich plasma (PRP), and extracellular vesicles (EVs), have shown clinical promise and are increasingly being incorporated into clinical aesthetic practice.^1,2,66,67 CaHA-CMC acts as a biostimulatory scaffold that provides structural support and mechanobiological cues, fostering a pro-regenerative microenvironment that supports progressive tissue remodeling and restoration of soft-tissue architecture. Evidence demonstrates coordinated renewal of ECM components, including collagen, elastin, and proteoglycans, alongside angiogenesis.^1,68–70 PLLA is another established biostimulatory injectable that promotes neocollagenesis through a localized foreign body response involving macrophages and fibroblasts. Histological and clinical evidence support increased collagen deposition and improvements in skin quality, although the organization and functional properties of the newly formed ECM have been less extensively characterized.^71–73 Bio-cue–based therapies such as PRP and EVs aim to enhance the local tissue environment through cell signaling.^1,67 PRP is obtained through centrifugation of the patient’s own blood and contains a range of growth factors and wound-healing proteins, with clinical studies reporting improvements in skin tone, texture, and firmness.^1,67,74 EVs, including exosomes and microvesicles, are lipid-enclosed nanoparticles that transport a diverse collection of biological signals including, among others, cytokines, micro-RNAs, and growth factors. These are suggested to mediate paracrine and autocrine effects, including immune modulation and stimulation of fibroblast activity.^1,75 Additional modalities discussed in the regenerative aesthetics literature include polynucleotides, photobiomodulation, and other emerging regenerative approaches, although standardization and clinical positioning remain in progress.^67,76 Broader overviews of regenerative aesthetic modalities and their proposed roles are available in recent reviews.^1–3,67 Looking ahead, advances in regenerative medicine such as cellular reprogramming, bioengineered tissues, and synthetic biology may further expand the therapeutic landscape, although their relevance to aesthetic practice remains largely prospective at present.^77–79

Within IA, regenerative interventions function as enablers of synergistic effects by supporting a more favorable tissue microenvironment that influences how skin responds to aesthetic procedures and recovers afterward. This creates a clinical window in which local structural and surface corrections can be layered more strategically to optimize both visible outcomes and underlying tissue health, particularly in individuals with diminished repair capacity driven by systemic aging biology.

Systemic Health Optimization

Systemic factors such as metabolic health, nutritional status, lifestyle factors (sleep, physical activity, and psychosocial stress), and/or environmental exposures can influence cutaneous healing and tissue repair by modulating inflammatory pathways, repair capacity, and biological aging processes.^80,81 Tobacco use is one clear example of an adverse systemic exposure that can accelerate skin aging and compromise the body’s global capacity for tissue remodeling and recovery. In identical twins, smokers exhibited more pronounced facial aging than their nonsmoking counterparts⁸² consistent with evidence that smoking impairs ECM homeostasis in human skin by reducing type I/III collagen synthesis and altering matrix remodeling.⁸³ In this context, functional medicine provides the critical systems-based approach within IA to help identify and address modifiable upstream determinants that shape tissue remodeling and recovery.

Functional Medicine

Functional medicine is a patient-centered clinical model informed by cellular pathways and systems biology. It evaluates how interactions among genetic factors, environmental exposures, and lifestyle contribute to patterns of dysfunction and uses personalized, evidence-informed interventions to address modifiable systemic health factors (Table 1).^84,85 Representative approaches include hormone optimization (eg, menopause related hormone therapy and/or correction of clinically relevant endocrine dysfunction), nutrition-focused strategies and targeted supplementation, lifestyle and stress regulation (eg, sleep and physical activity), and emerging interventions aimed at fundamental aging pathways (eg, nutrient sensing/mTOR signaling, mitochondrial and nicotinamide adenine dinucleotide [NAD⁺] biology, cellular senescence, and chronic inflammation).^9,86–89 While a comprehensive review of these interventions is beyond the scope of this paper, selected examples are highlighted below to illustrate key IA principles. Importantly, the strength of supporting evidence varies across these approaches, as some are based mainly on mechanistic, preclinical, associative, or indirect clinical data, while others remain investigational in aesthetic practice.

Nutrition is a foundational and broadly modifiable determinant of repair biology as adequate nutrition provides the substrates and cofactors required for effective immune responses, cutaneous barrier function, and tissue repair.^22,90 Nutritional interventions in IA should therefore emphasize adequacy of key macro- and micronutrients relevant to barrier function and collagen/ECM remodeling, alongside dietary patterns that support metabolic homeostasis and reduce inflammatory burden.^90–93 Grounded in IA’s “whole-tree” view, nutrition-focused strategies may also consider emerging precision nutrition approaches that integrate genetic and other omics data to better account for inter-individual variability in nutrient status and response to dietary interventions.⁹⁴ For example, common variants in key vitamin D-related genes, such as GC, contribute to inter-individual differences in circulating 25-hydroxyvitamin D [25(OH)D] and may influence responsiveness to supplementation, such that some individuals are predisposed to deficiency or show a blunted rise in 25(OH)D despite seemingly adequate sun exposure or intake.⁹⁵ Given the role of vitamin D signaling in skin biology and repair,⁹⁶ such differences may also be relevant to fibroblast function, with possible implications for tissue responsiveness in aesthetic practice. While the clinical utility of genomics-guided nutritional strategies for improving aesthetic treatment outcomes remains to be established, this underscores the potential relevance of a personalized approach that combines targeted assessment with dose titration and follow-up monitoring to achieve and maintain nutrient adequacy. Beyond nutrient status, IA may also incorporate microbiome-aware strategies, as the gut-skin axis represents another potentially relevant pathway in which host-microbe interactions and microbial metabolites can influence immune homeostasis and skin barrier function, as well as broader aging-related processes, reinforcing the whole-systems view central to IA.^23,86,97,98 While diet is a key influence, microbial balance may also be supported by targeted pre-/probiotics and broader barrier-supportive strategies that reduce disruption of cutaneous and gastrointestinal ecosystems.⁸⁶ Direct clinical evidence supporting microbiome-targeted interventions for aesthetic outcomes, however, remains limited.

Another clinically relevant area within IA is mitochondrial function, which sits at the nexus of multiple regulatory systems, regulating cellular energy availability while also influencing oxidative stress, inflammation, and cellular senescence.^99,100 With age, mitochondrial dysfunction reduces ATP availability, impairs collagen synthesis and repair processes, and compromises the oxidative defense systems needed for tissue recovery, thereby contributing to further aging-related decline.^99–101 In skin and underlying tissues, these effects may be further amplified by chronic ultraviolet (UV) exposure, which damages mitochondrial DNA and increases oxidative stress, contributing to matrix degradation and the characteristic features of photoaging, including wrinkles and textural changes.^100,102 Age-related decline in mitophagy, the selective removal of damaged mitochondria, further exacerbates this process by allowing dysfunctional mitochondria to accumulate and sustain oxidative and inflammatory signaling.^103,104 Consistent with this, age-related decline in NAD⁺, a critical coenzyme in mitochondrial function, has been implicated in skin aging¹⁰⁵ and nicotinamide mononucleotide, an NAD⁺ precursor, has shown promise in preclinical skin models by suppressing cellular senescence, enhancing proliferation, supporting ECM integrity, restoring collagen-related gene expression following UV damage, and promoting wound healing.^105–107 Other potential mitochondrial-supportive strategies include nutrient-based approaches, such as coenzyme Q10 and alpha-lipoic acid, as well as hormetic stressors such as heat therapy and intermittent fasting, which may help support mitochondrial function.^108–112 In the context of aesthetic medicine, such interventions may be relevant to procedural readiness and recovery by supporting cellular energy availability, limiting oxidative damage, and enhancing tissue remodeling capacity,^99,100 although the clinical evidence base in aesthetic practice remains early.

Endocrine changes associated with aging, including the menopausal transition in women and age-related androgen decline in men, also represent a highly relevant intervention area within IA. The menopausal transition, a key life stage in women marked by declining estrogen levels, is particularly well characterized in relation to skin aging. Estrogen deficiency reduces estrogen-receptor signaling in keratinocytes and dermal fibroblasts, which is associated with reduced ECM synthesis, increased matrix degradation, diminished oxidative-stress defense, and reduced vascular support, collectively manifesting as thinner, drier, less elastic, more wrinkled skin and slower repair.¹¹³ Hormone replacement therapy, when clinically indicated and appropriately monitored, can improve selected parameters of estrogen-deficient/aging skin, including collagen content, thickness, elasticity, and hydration.¹¹⁴ In men, by contrast, age-related androgen decline is typically more gradual and heterogeneous than the hormonal changes of menopause; however, available evidence suggests that declining testosterone may adversely affect skin thickness, elasticity, and sebum production over time, with potential implications for male facial aging.¹¹⁵ Together, these observations highlight that endocrine status is a clinically relevant modifier of skin structure and function and should be considered when individualizing IA plans.

Beyond nutrition and endocrine considerations, lifestyle interventions offer broadly applicable opportunities to support systemic conditions for tissue remodeling and recovery, as unhealthy lifestyle patterns can accelerate aging trajectories.^116–118 In addition, emerging longevity-directed strategies that aim to modulate aging-related biological pathways represent a rapidly evolving, yet largely investigational area. One example is rapamycin, a proposed “geroprotector” that acts primarily by inhibiting the mechanistic target of rapamycin complex 1 (mTORC1), a nutrient-sensing signaling complex involved in autophagy and cellular senescence.⁸⁹ In a small exploratory randomized trial, topical rapamycin reduced expression of p16^INK4A, a marker associated with cellular senescence, and increased levels of collagen VII, an essential component of anchoring fibrils that helps maintain basement-membrane integrity, alongside improvements in selected clinical and histological features of aged human skin.¹¹⁹ However, the human evidence base for many proposed geroprotective strategies (eg, metformin, NAD⁺ precursors) is still maturing, and off-label “anti-aging” use is variably regulated across regions.^37,80,88,89 Overviews of the longevity-directed interventions and the associated trial landscape can be found in recent reviews.^88,89

Synergy Across IA Pillars

Treating local and systemic factors in isolation may limit the magnitude and durability of remodeling outcomes. When used together, the three pillars function synergistically such that systemic optimization increases the likelihood that local interventions will trigger an efficient repair response, while local structural and regenerative treatments reduce the ongoing cutaneous load that would otherwise perpetuate maladaptive remodeling. As depicted in Figure 2, this alignment establishes biological conditions for enhanced aesthetic outcomes while supporting broader physiological resilience, thereby operationalizing a mutually reinforcing dynamic between skin and systemic health. In this way, IA reorients aesthetic medicine toward its health-focused roots and suggests that aesthetic practitioners may influence patient health trajectories more broadly than is conventionally assumed.

Figure 2.

The virtuous cycle of aesthetic and wellness. This conceptual model illustrates Integrative Aesthetics as a synergistic and mutually reinforcing system. The triangle represents the synergy among the three pillars (conventional aesthetic interventions, regenerative therapies, and functional medicine), which together create a biologically optimized foundation for improving the health of skin, underlying supporting tissues, and the system as a whole. The loop depicts the ongoing interaction between optimized skin and systemic health. Systemic vitality enhances tissue responsiveness, increasing the likelihood that local interventions achieve enhanced aesthetic benefits. In turn, improved skin health can reduce inflammatory burden and help preserve systemic resilience. All elements are interconnected, forming a continuous, mutually reinforcing dynamic that defines the Integrative Aesthetics approach.

Safety Considerations

Since IA involves selecting and/or combining interventions from its three pillars based on an individual’s clinical needs, health status, and treatment objectives, safe implementation must account for various factors. These include patient selection, characteristics of the product, device, and/or intervention, treatment order, clinician expertise, and the ability to recognize and handle adverse events. Although additional research and multidisciplinary consensus will be necessary to establish safety guidelines for IA as it becomes part of standardized care models, the following examples illustrate how these principles might be applied in practice. For instance, patient selection and treatment planning for energy-based devices should consider skin phototype, tissue characteristics, treatment area, device, and settings, as improper choices can increase the risk of pigmentary changes, burns, scarring, and other complications.^120,121 For HA fillers, safe use requires consideration of product characteristics and degradability, together with appropriate anatomical knowledge, injection technique, and preparedness to recognize and manage complications.^122–124 Emerging regenerative modalities such as EVs further highlight the importance of cautious adoption; although preliminary evidence is promising, their use in aesthetic practice remains an emerging area, with regulatory pathways varying by jurisdiction and standardized guidelines and expert consensus regarding their appropriate use still evolving.^1,75 Ultimately, safe IA practice requires each intervention and treatment sequence to be evidence-informed, individualized, and delivered within the clinician’s expertise.

Conclusion

In this paper, we present IA as an emerging conceptual framework that positions aesthetic optimization and systemic health improvement as coequal, mutually reinforcing goals. To guide implementation, IA is organized around three pillars (conventional aesthetic interventions, regenerative therapies, and functional medicine), which together provide a structured approach to strategic longitudinal care and reinforce the health-focused foundations of aesthetic practice through multidisciplinary coordination. In this way, IA aims to support aesthetic practitioners in achieving better outcomes while promoting skin longevity and overall patient well-being.

IA also represents a distinctive clinical opportunity within the broader shift toward prevention-oriented and longevity-focused care by linking aesthetic goals with modifiable determinants of systemic health. Aesthetic outcomes carry substantial patient-perceived value and can serve as a motivational anchor for systemic health optimization; improved systemic health enhances recovery and remodeling following local treatments, while visible aesthetic improvement reinforces adherence to supportive systemic interventions. Recognition of this reciprocal relationship may help extend the role of aesthetic consultations beyond isolated cosmetic enhancement and position aesthetic care as one component of a more comprehensive approach to health, well-being, and quality of life.

As a conceptual review based on a non-systematic, content-led synthesis, this paper provides a focused interpretation of the literature relevant to the proposed framework and is not intended as a comprehensive evidence review. IA has not yet been prospectively validated, and the maturity and clinical directness of the supporting evidence vary across its three pillars and individual interventions. Therefore, operationalizing IA into standardized care models and clinical protocols represents the next step in its development. This transition from concept to practice will require practical guidance on patient selection, principles for sequencing interventions across the three pillars, implementation tools that support coordinated care, and standardized measures of tissue quality (eg, skin stiffness and elasticity) to enable consistent patient assessment and evaluation of treatment response and durability. In parallel, further research is needed to strengthen the evidence base, particularly for emerging modalities within each pillar, and to define effectiveness, safety, and durability across patient phenotypes as clinical literature continues to mature.

As the field evolves, IA may also provide a clinically relevant framework for integrating future evidence-based innovations (eg, cellular reprogramming techniques, synthetic biology approaches) into aesthetic practice. Such continued progress will require multidisciplinary collaboration and careful attention not only to evidence, safety, and regulation, but also to ethical considerations, including equitable access.

Funding Statement

Merz Asia Pacific Pte. Ltd. funded medical writing support.

Abbreviations

25(OH)D, 25-hydroxyvitamin D; BoNT-A, Botulinum toxin type A; CaHA-CMC, Calcium hydroxyapatite-carboxymethyl cellulose; ECM, Extracellular matrix; EVs, Extracellular vesicles; HA, Hyaluronic acid; HRT, Hormone replacement therapy; IA, Integrative aesthetics; MFU-V, Microfocused ultrasound with visualization; MMP, Matrix metalloproteinase; NAD⁺, Nicotinamide adenine dinucleotide; PLLA, Poly-L-lactic acid; PRP, Platelet-rich plasma; RF, Radiofrequency; TGF-β, Transforming growth factor beta; UV, Ultraviolet.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

KG: Advisory board participation, speaker honoraria, travel grants: Merz Aesthetics. MG: Advisory board participation, speaker honoraria, travel grants: Croma Pharma. NC: Advisory board participation, speaker honoraria, travel grants: Merz Aesthetics. JG: Employee of Merz Asia Pacific Pte. Ltd. The authors report no other conflicts of interest in this work.